Acceptance of a Polypill Approach to Prevent Cardiovascular Disease Among a Sample of U.S. Physicians

作者：Viera Anthony J^*; Sheridan Stacey L; Edwards Teresa; Soliman Elsayed Z; Harris Russell; Furberg Curt D

来源：Preventive Medicine, 2011, 52(1): 10-15.

DOI：10.1016/j.ypmed.2010.09.016

• Polypill
• Cardiovascular disease prevention
• Physician acceptance

Objective. To examine US physicians' self-reported knowledge about the Polypill, factors considered in deciding whether to prescribe it, and acceptance of prescribing it for cardiovascular disease (CVD) prevention.
Methods. Numerical scales of 0 (lowest) to 5 (highest) were used to assess self-reported knowledge and importance of factors relevant to making a decision to prescribe a Polypill. Characteristics of physicians indicating they would prescribe a Polypill were compared.
Results. Among 952 physicians surveyed February through March 2010, mean self-rated knowledge about the Polypill was 2.0 +/- 1.5. Importance of degree of CVD event reduction, cost, and side effects were rated with means of 4.4 +/-, 4.3, and 4.3, respectively. 83% of respondents indicated they would "definitely" or "probably" prescribe it for high-risk patients; 62% would do so for moderate risk patients. Physicians with self-rated knowledge at >= 75th percentile were more likely to indicate they would prescribe a Polypill for moderate risk (adjusted OR 2.16; 95% CI 1.60-2.93) and high-risk (adjusted OR 1.57; 95% CI 1.07-2.32) patients.
Conclusion. Among this sample of physicians, there is relatively high acceptance of prescribing a Polypill for CVD prevention despite relatively modest knowledge about it.

• 出版日期2011-1